相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ANEMIA DURING TREATMENT WITH PEGINTERFERON ALFA-2B/RIBAVIRIN WITH OR WITHOUT BOCEPREVIR IS ASSOCIATED WITH HIGHER SVR RATES: ANALYSIS OF PREVIOUSLY UNTREATED AND PREVIOUS-TREATMENT-FAILURE PATIENTS
M. S. Sulkowski et al.
JOURNAL OF HEPATOLOGY (2011)
ANEMIA HAD NO EFFECT ON EFFICACY OUTCOMES IN TREATMENT-NAIVE PATIENTS WHO RECEIVED TELAPREVIR-BASED REGIMEN IN THE ADVANCE AND ILLUMINATE PHASE 3 STUDIES
M. S. Sulkowski et al.
JOURNAL OF HEPATOLOGY (2011)
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
JOURNAL OF HEPATOLOGY (2011)
New direct-acting antivirals' combination for the treatment of chronic hepatitis C
Tarik Asselah et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Drug Rash with Eosinophilia and Systemic Symptoms due to Telaprevir
H. Montaudie et al.
DERMATOLOGY (2010)
Hepatitis C Virus Treatment-Related Anemia Is Associated With Higher Sustained Virologic Response Rate
Mark S. Sulkowski et al.
GASTROENTEROLOGY (2010)
Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
Kay Seden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment
K. Rajender Reddy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases
J Lübbe et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Epoetin alfa maintains ribavirin dose in HCV-infected patients: A prospective, double-blind, randomized controlled study
NH Afdhal et al.
GASTROENTEROLOGY (2004)
ABC of burns - Initial management of a major burn: II - assessment and resuscitation
S Hettiaratchy et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard et al.
GASTROENTEROLOGY (2002)
分享论文
